Join to View Full Profile
Winship Cancer Institute 1365 Clifton Rd Building CAtlanta, GA 30322
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. NizarJacques Bahlis, MD is an oncologist in Atlanta, Georgia. He is currently licensed to practice medicine in Georgia, Florida, and Ohio.
Education & Training
St Joseph's University Medical SchoolClass of 1995
Certifications & Licensure
GA State Medical License 2017 - 2019
FL State Medical License 2002 - 2009
OH State Medical License 2002 - 2007
IN State Medical License 1998 - 2003
Publications & Presentations
PubMed
- Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexametha...Aurore Perrot, Thierry Facon, Torben Plesner, Saad Z Usmani, Shaji Kumar
European Journal of Haematology. 2025-05-01 - Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 C...Saad Z Usmani, Thierry Facon, Vania Hungria, Nizar J Bahlis, Christopher P Venner
Nature Medicine. 2025-04-01 - 1 citationsDaratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.Thierry Facon, Philippe Moreau, Katja Weisel, Hartmut Goldschmidt, Saad Z Usmani
Leukemia. 2025-04-01
Press Mentions
TALVEY® (Talquetamab-Tgvs) and DARZALEX FASPRO® (Daratumumab and Hyaluronidase-Fihj) Based Combination Shows Deep and Durable Responses in Patients with Relapsed or Refractory Multiple MyelomaSeptember 27th, 2024
